This company listing is no longer active
Meridian Bioscience Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 21.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2023 | 288 | 35 | N/A | N/A | 2 |
9/30/2022 | 333 | 42 | 74 | 82 | N/A |
6/30/2022 | 344 | 43 | 88 | 95 | N/A |
3/31/2022 | 339 | 62 | 82 | 91 | N/A |
12/31/2021 | 313 | 60 | 59 | 77 | N/A |
9/30/2021 | 318 | 71 | 49 | 67 | N/A |
6/30/2021 | 306 | 71 | 51 | 69 | N/A |
3/31/2021 | 327 | 87 | 60 | 74 | N/A |
12/31/2020 | 299 | 70 | 63 | 68 | N/A |
9/30/2020 | 254 | 46 | 45 | 48 | N/A |
6/30/2020 | 240 | 44 | 36 | 39 | N/A |
3/31/2020 | 204 | 21 | 28 | 31 | N/A |
12/31/2019 | 197 | 19 | 29 | 32 | N/A |
9/30/2019 | 201 | 24 | 32 | 36 | N/A |
6/30/2019 | 203 | 26 | 36 | 40 | N/A |
3/31/2019 | 207 | 27 | 38 | 42 | N/A |
12/31/2018 | 213 | 26 | 35 | 39 | N/A |
9/30/2018 | 214 | 24 | 31 | 35 | N/A |
6/30/2018 | 210 | 24 | 28 | 32 | N/A |
3/31/2018 | 209 | 18 | 26 | 30 | N/A |
12/31/2017 | 206 | 22 | 29 | 34 | N/A |
9/30/2017 | 201 | 22 | 37 | 41 | N/A |
6/30/2017 | 198 | 21 | 39 | 44 | N/A |
3/31/2017 | 199 | 30 | 39 | 44 | N/A |
12/31/2016 | 195 | 30 | 34 | 38 | N/A |
9/30/2016 | 196 | 32 | 33 | 37 | N/A |
6/30/2016 | 195 | 35 | N/A | 38 | N/A |
3/31/2016 | 192 | 36 | N/A | 41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 0K0K's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 0K0K's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if 0K0K's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 0K0K's revenue is forecast to grow faster than the UK market.
High Growth Revenue: Insufficient data to determine if 0K0K's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0K0K's Return on Equity is forecast to be high in 3 years time